Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 10, 2011 - Issue 1
Submit an article Journal homepage
736
Views
29
CrossRef citations to date
0
Altmetric
Drug Safety Evaluations

Zoledronic acid

Robert Coleman University of Sheffield, Weston Park Hospital, Academic Unit of Clinical Oncology, Sheffield, S10 2SJ, UK + 44 114 226 5208; +44 114 226 5678; [email protected]
,
Roger Burkinshaw University of Sheffield, Weston Park Hospital, Academic Unit of Clinical Oncology, Sheffield, S10 2SJ, UK + 44 114 226 5208; +44 114 226 5678; [email protected]
,
Matthew Winter University of Sheffield, Weston Park Hospital, Academic Unit of Clinical Oncology, Sheffield, S10 2SJ, UK + 44 114 226 5208; +44 114 226 5678; [email protected]
,
Helen Neville-Webbe Clatterbridge Oncology Centre, Liverpool, UK
,
Jim Lester University of Sheffield, Weston Park Hospital, Academic Unit of Clinical Oncology, Sheffield, S10 2SJ, UK + 44 114 226 5208; +44 114 226 5678; [email protected]
,
Emma Woodward University of Sheffield, Weston Park Hospital, Academic Unit of Clinical Oncology, Sheffield, S10 2SJ, UK + 44 114 226 5208; +44 114 226 5678; [email protected]; St James Institute of Oncology, University of Leeds, UK
&
Janet Brown University of Sheffield, Weston Park Hospital, Academic Unit of Clinical Oncology, Sheffield, S10 2SJ, UK + 44 114 226 5208; +44 114 226 5678; [email protected]; St James Institute of Oncology, University of Leeds, UK
 show all
Pages 133-145 | Published online: 29 Nov 2010

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Allan Lipton. (2011) Zoledronic acid: multiplicity of use across the cancer continuum. Expert Review of Anticancer Therapy 11:7, pages 1001-1014.
Read now

Articles from other publishers (28)

Winston Adam Camargo, Jan Willem Hoekstra, John A. Jansen & Jeroen J. J. P. van den Beucken. (2023) Influence of bisphosphonate treatment on bone substitute performance in osteoporotic conditions. Clinical Implant Dentistry and Related Research 25:3, pages 490-501.
Crossref
Yi Yu, Chaoan Liang, Ruogu Xu, Tianlu Wang, Feilong Deng & Xiaolin Yu. (2021) Titanium implant alters the effect of zoledronic acid on the behaviour of endothelial cells. Oral Diseases 28:7, pages 1968-1978.
Crossref
Mehtap Kara. (2022) Evaluation of the Effect of Zoledronic Acid Exposure on Nerve Cell in SH-SY5Y Neuroblastoma Cells. Turkish Journal of Osteoporosis 28:2, pages 153-157.
Crossref
Ana García, María Victoria Cabañas, Juan Peña & Sandra Sánchez-Salcedo. (2021) Design of 3D Scaffolds for Hard Tissue Engineering: From Apatites to Silicon Mesoporous Materials. Pharmaceutics 13:11, pages 1981.
Crossref
Yeesha Poon, Petros Pechlivanoglou, Shabbir M.H. Alibhai, David Naimark, Jeffrey S. Hoch, Emmanuel Papadimitropoulos, Mary-Ellen Hogan & Murray Krahn. (2018) Systematic review and network meta-analysis on the relative efficacy of osteoporotic medications: men with prostate cancer on continuous androgen-deprivation therapy to reduce risk of fragility fractures. BJU International 121:1, pages 17-28.
Crossref
Caroline Wilson, Fiona Taylor & Robert Coleman. 2018. Side Effects of Medical Cancer Therapy. Side Effects of Medical Cancer Therapy 439 460 .
Cristian Caimmi, Maurizio Rossini, Ombretta Viapiana, Luca Idolazzi, Giovanni Adami & Davide Gatti. (2017) Could γ/δ T Cells Explain Adverse Effects of Zoledronic Acid? Comment on the Article by Reinhardt et al. Arthritis & Rheumatology 69:6, pages 1339-1339.
Crossref
Sarah L. Clark & Erin M. Nystrom. (2016) A Case of Severe, Prolonged, Refractory Hypophosphatemia After Zoledronic Acid Administration. Journal of Pharmacy Practice 29:2, pages 172-176.
Crossref
XIN HUANG, SHILONG HUANG, FENGJIN GUO, FEI XU, PENG CHENG, YAPING YE, YONGHUI DONG, WEI XIANG & ANMIN CHEN. (2016) Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro. Molecular Medicine Reports 13:1, pages 613-622.
Crossref
J.L. Paris, J. Román, M. Manzano, M.V. Cabañas & M. Vallet-Regí. (2015) Tuning dual-drug release from composite scaffolds for bone regeneration. International Journal of Pharmaceutics 486:1-2, pages 30-37.
Crossref
Fahim Vohra, Mohammad Qasim Al-Rifaiy, Khalid Almas & Fawad Javed. (2014) Efficacy of systemic bisphosphonate delivery on osseointegration of implants under osteoporotic conditions: Lessons from animal studies. Archives of Oral Biology 59:9, pages 912-920.
Crossref
F. Errassifi, S. Sarda, A. Barroug, A. Legrouri, H. Sfihi & C. Rey. (2014) Infrared, Raman and NMR investigations of risedronate adsorption on nanocrystalline apatites. Journal of Colloid and Interface Science 420, pages 101-111.
Crossref
Robert E. Coleman & Ingunn Holen. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 739 763.e3 .
Emma J. RathboneJanet E. BrownHelen C. MarshallMichelle CollinsonVictoria LiversedgeGeraldine A. MurdenDavid CameronRichard BellSaiqa SpensleyRajiv AgrawalRema JyothirmayiPrabir ChakrabortiFrances YuilleRobert E. Coleman. (2013) Osteonecrosis of the Jaw and Oral Health–Related Quality of Life After Adjuvant Zoledronic Acid: An Adjuvant Zoledronic Acid to Reduce Recurrence Trial Subprotocol (BIG01/04). Journal of Clinical Oncology 31:21, pages 2685-2691.
Crossref
Thierry Lebret, Jean-Loup Mouysset, Alain Lortholary, Claude El Kouri, Laurent Bastit, Meryem Ktiouet, Khemaies Slimane, Xavier Murraciole & Stéphane Guérif. (2013) Home-based zoledronic acid infusion therapy in patients with solid tumours: compliance and patient–nurse satisfaction. Supportive Care in Cancer 21:6, pages 1613-1620.
Crossref
Thierry Lebret, Jean-Loup Mouysset, Alain Lortholary, Claude El Kouri, Laurent Bastit, Meryem Ktiouet, Slimane Khemaies, Xavier Murraciole & Stéphane Guérif. (2013) Traitement à domicile par l’acide zolédronique chez des patients atteints de tumeurs solides : observance et satisfaction du patient et de l’infirmier. Bulletin du Cancer 100:3, pages 247-257.
Crossref
Patricia Pascaud, Pierre Gras, Yannick Coppel, Christian Rey & Stéphanie Sarda. (2013) Interaction between a Bisphosphonate, Tiludronate, and Biomimetic Nanocrystalline Apatites. Langmuir 29:7, pages 2224-2232.
Crossref
M.C. Winter & R.E. Coleman. (2013) Bisphosphonates in the Adjuvant Treatment of Breast Cancer. Clinical Oncology 25:2, pages 135-145.
Crossref
Carina Cardemil, Omar M. Omar, Birgitta Norlindh, Cecilia L. Wexell & Peter Thomsen. (2013) The effects of a systemic single dose of zoledronic acid on post-implantation bone remodelling and inflammation in an ovariectomised rat model. Biomaterials 34:5, pages 1546-1561.
Crossref
Caterina Musolino & Alessandro Allegra. 2013. Pathobiology of Cancer Regimen-Related Toxicities. Pathobiology of Cancer Regimen-Related Toxicities 249 282 .
Caroline Wilson, Fiona G. Taylor & Robert E. Coleman. 2013. Side Effects of Medical Cancer Therapy. Side Effects of Medical Cancer Therapy 531 567 .
Maria A. Lopez-Olivo, Nimit A. Shah, Greg Pratt, Jan M. Risser, Elaine Symanski & Maria E. Suarez-Almazor. (2012) Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis. Supportive Care in Cancer 20:11, pages 2985-2998.
Crossref
P Pascaud, R Bareille, C Bourget, J Amédée, C Rey & S Sarda. (2012) Interaction between a bisphosphonate, tiludronate and nanocrystalline apatite: in vitro viability and proliferation of HOP and HBMSC cells . Biomedical Materials 7:5, pages 054108.
Crossref
Dominique Heymann. (2012) Anti-RANKL therapy for bone tumours: Basic, pre-clinical and clinical evidences. Journal of Bone Oncology 1:1, pages 2-11.
Crossref
Janet E. Brown & Robert E. Coleman. (2012) Denosumab in patients with cancer—a surgical strike against the osteoclast. Nature Reviews Clinical Oncology 9:2, pages 110-118.
Crossref
Dehao Fu, Xianfeng He, Shuhua Yang, Weihua Xu, Tao Lin & Xiaobo Feng. (2011) Zoledronic acid inhibits vasculogenic mimicry in murine osteosarcoma cell line in vitro. BMC Musculoskeletal Disorders 12:1.
Crossref
Nagi S. El Saghir, Arafat Tfayli, Hassan A. Hatoum, Zahi Nachef, Phuong Dinh & Ahmad Awada. (2011) Treatment of metastatic breast cancer: State-of-the-art, subtypes and perspectives. Critical Reviews in Oncology/Hematology 80:3, pages 433-449.
Crossref
R. Coleman, E. Woodward, J. Brown, D. Cameron, R. Bell, D. Dodwell, M. Keane, M. Gil, C. Davies, R. Burkinshaw, S. J. Houston, R. J. Grieve, P. J. Barrett-Lee & H. Thorpe. (2011) Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01–04) for women with stage II/III breast cancer. Breast Cancer Research and Treatment 127:2, pages 429-438.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.